ROQUEFORT THERAPEUTICS PLC
Biotechnology company developing medicines for therapy-resistant cancers.
ROQ | IL
Overview
Corporate Details
- ISIN(s):
- GB00BMDQ2T15
- LEI:
- 254900P4SISIWOR9RH34
- Country:
- United Kingdom
- Address:
- 85 Great Portland Street, W1W 7LT London
- Website:
- https://www.roquefortplc.com/
Description
Roquefort Therapeutics PLC is a biotechnology company focused on developing next-generation, first-in-class medicines for hard-to-treat cancers. The company operates within the high-growth immuno-oncology market. Its portfolio consists of five novel, patent-protected, pre-clinical anti-cancer programs. These programs are designed to target cancers that have become resistant to existing therapies. Roquefort Therapeutics utilizes a distributed R&D model, combining its in-house expertise and laboratory facilities with a network of partnerships with leading academic cancer research centers to advance its development strategy.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-09-22 12:42 |
Investor Presentation via Investor Meet Company
|
English | 13.3 KB | ||
| 2023-08-14 08:00 |
Expansion of Patent Portfolio
|
English | 16.2 KB | ||
| 2023-08-07 08:00 |
Development of New Novel siRNA Therapeutics
|
English | 21.4 KB | ||
| 2023-08-02 08:00 |
Director/PDMR Shareholding
|
English | 25.5 KB | ||
| 2023-07-12 11:27 |
Director/PDMR Shareholding
|
English | 25.7 KB | ||
| 2023-06-29 11:05 |
Results of AGM
|
English | 29.5 KB | ||
| 2023-06-29 08:00 |
AGM Statement
|
English | 19.6 KB | ||
| 2023-06-27 08:00 |
Investor Presentation via Investor Meet Company
|
English | 13.3 KB | ||
| 2023-06-26 15:41 |
Director/PDMR Shareholding
|
English | 25.5 KB | ||
| 2023-06-26 11:36 |
Director/PDMR Shareholding
|
English | 25.7 KB | ||
| 2023-06-26 11:00 |
Director/PDMR Shareholding
|
English | 26.0 KB | ||
| 2023-06-22 08:00 |
RNA Medicine Shows In Vitro Anti-Cancer Efficacy
|
English | 23.7 KB | ||
| 2023-06-19 08:00 |
Antibody Program Results & Orphan Drug Indication
|
English | 21.2 KB | ||
| 2023-06-13 08:00 |
Anti-Cancer MDK mRNA - Positive in vitro Results
|
English | 22.3 KB | ||
| 2023-06-07 11:11 |
Restoration of Trading
|
English | 12.9 KB |
Automate Your Workflow. Get a real-time feed of all ROQUEFORT THERAPEUTICS PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ROQUEFORT THERAPEUTICS PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ROQUEFORT THERAPEUTICS PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
